Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypogonadotropic Hypogonadism: early-phase trial registry
4 of 7 indexed Hypogonadotropic Hypogonadism trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Hypogonadotropic Hypogonadism: 7 US clinical trials tracked, 4 recruiting.
Hypogonadotropic Hypogonadism is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Stephanie B. Seminara, MD, running 4 of these trials.
Enrollment posture brief
Registry condition hypogonadotropic-hypogonadism
OPEN 4 | RECR 57% | LATE 1 | EARLY 4 | RANK #2497 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Hypogonadotropic Hypogonadism lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hypogonadotropic Hypogonadism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hypogonadotropic Hypogonadism is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hypogonadotropic Hypogonadism research.
Stephanie B. Seminara, MD accounts for 4 of 7 trials (57.1%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Hypogonadotropic Hypogonadism trials plan to enrol fewer than 100 people.
Median target enrolment is 32 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
Hypogonadotropic Hypogonadism research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
The Molecular Basis of Inherited Reproductive Disorders
Stephanie B. Seminara, MD
NCT05971836
Kisspeptin Administration Subcutaneously to Patients With IHH
Stephanie B. Seminara, MD
NCT05896293
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
University of Colorado, Denver
NCT06357442
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Stephanie B. Seminara, MD
NCT07224438
Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions
Amneal Pharmaceuticals
NCT02110368
Opioid Antagonism in Hypogonadotropic Hypogonadism
Stephanie B. Seminara, MD
NCT04975334
Effect of Intranasal Insulin on LH Concentrations in Man
Texas Tech University Health Sciences Center
NCT02154477
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hypogonadotropic Hypogonadism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hypogonadotropic Hypogonadism trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hypogonadotropic Hypogonadism page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Hypogonadotropic Hypogonadism trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Stephanie B. Seminara, MD sponsors the most Hypogonadotropic Hypogonadism trials on record, review their full trial history before evaluating a specific study. See Stephanie B. Seminara, MD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypogonadotropic Hypogonadism condition card totals 7 registered trials; most-linked intervention kisspeptin 112-121; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.